Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Use the drop down menu to choose from the possible solids: Tetrahedron, Cube, Octahedron, Dodecahedron, Icosahedron, or "My Own Net." Manipulate set shapes in the workspace. Click and drag the shape ...